Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication indicated for attention deficit hyperactivity disorder in youngsters and individuals. In Canada, its distribution is overseen by Health https://lisdexamfetamine-in-cana429786.blog-eye.com/43167416/lisdexamfetamine-in-canada-a-detailed-guide